News & Views
Partnership to Advance Clinical Research in South Korea
Oct 29 2012
ICON plc (Dublin), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and Korea National Enterprise for Clinical Trials (KoNECT) have signed a partnership agreement that aims to advance the clinical trials industry in South Korea.
Through the agreement, ICON and KoNECT will collaborate on a series of educational events for local and multinational pharmaceutical companies, investigators and industry officials.
“South Korea has become a key country for clinical development and ICON has had a well-established presence there since 2005,” commented Wei Ming Goh, ICON’s Vice President, Asia-Pacific.
“Our agreement with KoNECT supports our mutual interest in developing and growing the clinical research industry in South Korea and demonstrates our on-going commitment to the Asia Pacific region.”
KoNECT President, Professor Sang-Goo Shin, added, “We are delighted to collaborate with a leading clinical research organisation such as ICON that has a wealth of expertise in both local and global clinical development programmes. Together we can develop high quality clinical research professionals and a clinical trials infrastructure that can support the increased demand from local and global pharma companies."
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Nov 27 2024 Istanbul, Turkey
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE